Efficacy of two professionally applied desensitizing agent.

Phase 4

• Conditions: Health Condition 1: null- Patients with dentinal hypersensitivity

• Registration Number: CTRI/2018/05/013732
• Lead Sponsor: Dr Swati G Naidu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Individuals aged 20 years and above with a history of dentinal hypersensitivity

2. Subjects with at least 20 natural permanent teeth.

3. Patient who were willing to participate in the study with wriiten informed consent.

Exclusion Criteria

1.Teeth with caries, defective restorations , fractured teeth, and gingival inflammation.

2.Subjects with the presence of orthodontic appliances.

3.Patients with a history of periodontal surgery in the area of selected tooth during the previous three months from the day of examination.

4.Subjects who used any product that could influence the dentinal hypersensitivity of the patient in the 30 days prior to the baseline were excluded.

5.Pregnant or lactating females were excluded.

6.Subjects on prescription of NSAIDâ??s and Aspirin.

7.Subjects with known hypersensitivity to silver or other heavy metal ions were excluded

Study & Design

• Study Type: PMS
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual analogue pain scale score for assessing pain due to hypersensitivityTimepoint: Visual analogue pain scale score for assessing pain due to hypersensitivity immediately after intervention

Secondary Outcome Measures

Name	Time	Method
visual analogue pain scale score for assessing pain due to hypersentivityTimepoint: at the end of 7 days, 1 month, 3 months and 6 months from the day of intervention given.